| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.3 | 1e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.28 | 3e-05 |